Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART621 dose-ranging study in rheumatoid arthritis on methotrexate
2008-006930-92Phase 2Terminated
- Sponsor
- Arana Therapeutics
- Start
- Jan 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing ART621 plus methotrexate with Placebo plus methotrexate (2 arms). Primary endpoint: ACR20 response at Week 12. Started Jan 2009; status: terminated.
02
Drugs
placulumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-006930-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006930-92.